Press Releases

Press Releases

or

September 17, 2020
CAMBRIDGE, Mass. & BEIJING --(BUSINESS WIRE)--Sep. 17, 2020-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the first reported data from RATIONALE 304, the Phase 3 trial
August 25, 2020
CAMBRIDGE, Mass. & BEIJING --(BUSINESS WIRE)--Aug. 25, 2020-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced the appointment of Corsee Sanders , Ph.D.
August 6, 2020
CAMBRIDGE, Mass. and BEIJING, China , Aug. 06, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today reported recent business highlights, anticipated upcoming